One stock that keeps coming up on my LT tailwind ST headwind scan is MVP.
Non opioid pain relief. Increasing footprint in EU & in talks with US FDA.
Metric improvement modest but next 2 years could be dramatic.
Here is latest presso, MC around 350m but if they get into the US with non opi pain relief anything could happen. (next PME?)
Not a trading stock but more an investment 2 to 3 year play with appropriate stop strategy.
NB. Multiple director buying has been sustained last 2 to 3 months at prices above current, one for the WL.
